ENTRY       D11828                      Drug
NAME        Clervonafusp alfa (USAN/INN)
FORMULA     C6586H10059N1759O1975S46
EXACT_MASS  146861.7908
MOL_WEIGHT  146952.929
SEQUENCE    (Heavy chain)
            EVQLQESGGG VVQPGGSLRL SCAASGFTFS NYGMHWIRQA PGKGLEWVSY ISSGSSTIYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRSED TAVYYCARRG LLLDYWGQGT LVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTGGSGGG SGGGSGGDAQ
            AHPGRPRAVP TQCDVPPNSR FDCAPDKAIT QEQCEARGCC YIPAKQGLQG AQMGQPWCFF
            PPSYPSYKLE NLSSSEMGYT ATLTRTTPTF FPKDILTLRL DVMMETENRL HFTIKDPANR
            RYEVPLETPH VHSRAPSPLY SVEFSEEPFG VIVRRQLDGR VLLNTTVAPL FFADQFLQLS
            TSLPSQYITG LAEHLSPLML STSWTRITLW NRDLAPTPGA NLYGSHPFYL ALEDGGSAHG
            VFLLNSNAMD VVLQPSPALS WRSTGGILDV YIFLGPEPKS VVQQYLDVVG YPFMPPYWGL
            GFHLCRWGYS STAITRQVVE NMTRAHFPLD VQWNDLDYMD SRRDFTFNKD GFRDFPAMVQ
            ELHQGGRRYM MIVDPAISSS GPAGSYRPYD EGLRRGVFIT NETGQPLIGK VWPGSTAFPD
            FTNPTALAWW EDMVAEFHDQ VPFDGMWIDM NEPSNFIRGS EDGCPNNELE NPPYVPGVVG
            GTLQAATICA SSHQFLSTHY NLHNLYGLTE AIASHRALVK ARGTRPFVIS RSTFAGHGRY
            AGHWTGDVWS SWEQLASSVP EILQFNLLGV PLVGADVCGF LGNTSEELCV RWTQLGAFYP
            FMRNHNSLLS LPQEPYSFSE PAQQAMRKAL TLRYALLPHL YTLFHQAHVA GETVARPLFL
            EFPKDSSTWT VDHQLLWGEA LLITPVLQAG KAEVTGYFPL GTWYDLQTVP VEALGSLPPP
            PAAPREPAIH SEGQWVTLPA PLDTINVHLR AGYIIPLQGP GLTTTESRQQ PMALAVALTK
            GGEARGELFW DDGESLEVLE RGAYTQVIFL ARNNTIVNEL VRVTSEGAGL QLQKVTVLGV
            ATAPQQVLSN GVPVSNFTYS PDTKVLDICV SLLMGEQFLV SWC
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ISCRASKSVS TSSYSYMHWY QQKPEKAPKL LIKYASYLQS
            GVPSRFSGSG SGTDFTLTIS SLQPEDVATY YCQHSREFPW TFGAGTKLEL KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H143-H199, H219-L218, H253-H280, H263-H279, H274-H298, H704-H729, H818-H829, H1109-H1123, L23-L92, L138-L198)
  TYPE      Peptide
EFFICACY    Inherited metabolic disorder therapeutic agent
COMMENT     Fusion protein, enzyme-antibody
            Treatment of Pompe disease
TARGET      GAA [HSA:2548] [KO:K12316]
            SLC29A2 (ENT2) [HSA:3177] [KO:K15014]
  PATHWAY   hsa00052(2548)  Galactose metabolism
            hsa00500(2548)  Starch and sucrose metabolism
            hsa04142(2548)  Lysosome
BRITE       Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC29
                SLC29A2 (ENT2)
                 D11828  Clervonafusp alfa (USAN/INN)
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GAA
                 D11828  Clervonafusp alfa (USAN/INN)
DBLINKS     CAS: 2145123-44-8
            PubChem: 405226693
///
